Hearscape
← Organizations
Organization

NYU Langone Health

Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.

All ProgramsTherapeuticsDevices
Open filtered programs
Programs
4
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
4
0 open data checks
Company / Institution Links
1 / 3
industry vs non-industry records
Competitive Density
7
Pipeline Velocity
50
Completion Signal
50

Programs by Stage

Early Phase 11
Phase 32
Interventional/NA1

Trial / Program Status

Active2
Discontinued1
Unknown1

Modality Mix

Behavioral/Rehabilitation1
Cochlear/Auditory Implant1
Hearing Aid/Software1
Small Molecule1

Indication Coverage

Hearing Loss3
Age-Related Hearing Loss1
Sensorineural Hearing Loss1
Single-Sided Deafness1
Tinnitus1

Program Types

Software/Neurotech2
Procedure/Rehab1
Therapeutic1

Population Tags

adult3
cochlear-implant2
hearing-aid-user2
speech-in-noise2
age-related1
cognitive-health1
older-adult1
pediatric1
post-implant-programming1
rehabilitation1

Strong-Evidence Records

0 records
No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

4 checked · 0 open checks
NYU alternative frequency mapping SSD-CI study
Details checked
Cochlear/Auditory ImplantInterventional/NAActive

Recruiting NYU study evaluating alternative cochlear-implant frequency allocation tables in newly implanted single-sided deaf cochlear implant users to reduce place-pitch mismatch and improve sound quality, device use, and speech perception.

Data checks: institution-led-study, federal-sponsor
ACHIEVE brain-health hearing intervention follow-up study
Details checked
Behavioral/RehabilitationPhase 3Active

Active-not-recruiting Phase 3 follow-up to ACHIEVE evaluating long-term effects of best-practice hearing rehabilitation, including hearing aids and individualized audiology sessions, on cognitive decline and brain-health outcomes in older adults.

Data checks: institution-led-study, federal-sponsor
NYU High-Dose Intranasal Oxytocin Tinnitus Study
Details checked
Small MoleculePhase 3Discontinued

Terminated Phase 3 pilot proof-of-concept study of high-dose intranasal oxytocin nasal spray versus placebo for tinnitus.

Data checks: institution-led-study, registry-only-evidence
York Sound babble noise-reduction algorithm for cochlear implant users
Details checked
Hearing Aid/SoftwareEarly Phase 1Unknown

Software algorithm intended to remove competing background talker babble from audio signals for cochlear implant users, improving speech recognition in noisy multi-talker environments.

Data checks: registry-only-current-status, no-independent-corroboration-found